The mechanisms of the anticoagulant and antithrombotic medications used in the treatment of acute coronary syndrome (ACS).
Albritton
S
S
Heart Institute of Spokane, Wash, USA.
Shuler
L
L
Schatz
K
K
D000925:Anticoagulants / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000503:physiopathology; D003327:Coronary Disease / Q000188:drug therapy* / Q000503:physiopathology; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D013577:Syndrome; D013927:Thrombosis / Q000503:physiopathology
D000925:Anticoagulants; D005343:Fibrinolytic Agents